Literature DB >> 26202022

p53 family members - important messengers in cell death signaling in photodynamic therapy of cancer?

Pilar Acedo1, Joanna Zawacka-Pankau.   

Abstract

TP53 is one of the genes most frequently inactivated in cancers. Mutations in TP53 gene are linked to worse prognosis and shorter overall survival of cancer patients. TP53 encodes a critical tumor suppressor, which dictates cell fate decisions upon stress stimuli. As a sensor of cellular stress, p53 is a relevant messenger of cell death signaling in ROS-driven photodynamic therapy (PDT) of cancer. The significant role of p53 in response to PDT has been reported for several clinically approved photosensitizers. Multiple reports described that wild-type p53 contributes to cell killing upon photodynamic therapy with clinically approved photosensitizers but the mechanism is still not fully understood. This work outlines the diverse functions of p53 family members in cancer cells' susceptibility and resistance to PDT. In summary p53 and p53 family members are emerging as important mediators of cell death signaling in photodynamic therapy of cancer, however the mechanism of cell death provoked during PDT might differ depending on the tissue type and the photosensitizer applied.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202022     DOI: 10.1039/c5pp00251f

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  8 in total

1.  Effects of Visible-Light Irradiation of Protoporphyrin IX on the Self-Assembly of Tubulin Heterodimers.

Authors:  Alicia Vall-Sagarra; Brady McMicken; Santi Nonell; Lorenzo Brancaleon
Journal:  Chemphyschem       Date:  2016-08-30       Impact factor: 3.102

Review 2.  The Photomodulation Activity of Metformin Against Oral Microbiome.

Authors:  Shima Afrasiabi; Maryam Pourhajibagher; Abbas Bahador
Journal:  J Lasers Med Sci       Date:  2019-07-06

3.  Biophysical characterization of the interaction of human albumin with an anionic porphyrin.

Authors:  Sarah C Rozinek; Robert J Thomas; Lorenzo Brancaleon
Journal:  Biochem Biophys Rep       Date:  2016-07-18

4.  The Effect of Phototherapy on Cancer Predisposition Genes of Diabetic and Normal Human Skin Fibroblasts.

Authors:  Pongsathorn Chotikasemsri; Boonsin Tangtrakulwanich; Surasak Sangkhathat
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

5.  Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma.

Authors:  Jinying Wei; Guangping Meng; Jing Wu; Qiang Zhang; Jie Zhang
Journal:  Sci Rep       Date:  2021-05-03       Impact factor: 4.379

Review 6.  Drug Carrier for Photodynamic Cancer Therapy.

Authors:  Tilahun Ayane Debele; Sydney Peng; Hsieh-Chih Tsai
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

7.  Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.

Authors:  Kuijie Liu; Weidong Chen; Sanlin Lei; Li Xiong; Hua Zhao; Dong Liang; Zhendong Lei; Nanjiang Zhou; Hongliang Yao; Ying Liang
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

8.  Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer.

Authors:  Zhong Ni; Xiting Wang; Tianchen Zhang; Linlin Li; Jianxue Li
Journal:  Exp Ther Med       Date:  2018-02-02       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.